Lesser doses for perioral treatment than for upper facial applications are used since the oral musculature responds far more strongly to precisely the same BTX-A dosing. Just one planning of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia. The https://botulinum-toxins73950.wikiinside.com/2195258/botulinum_toxin_symptoms_fundamentals_explained